Centauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives
Centauri is excited to announce that we have been selected to receive a £1M grant under the first round of @PACE-AMR funding which will support the continued development of our novel immunotherapeutic platform. Founded in 2023 by LifeArc, Innovate UK and Medicines Discovery Catapult, PACE is a new and comprehensive…